Exact Mass: 420.0989122
Exact Mass Matches: 420.0989122
Found 82 metabolites which its exact mass value is equals to given mass value 420.0989122,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
3-Demethyldigicitrin
5,5,7-trihydroxy-2,3,4,6,8-pentamethoxyflavone|5,7,5-trihydroxy-3,6,8,2,4-pentamethoxyflavone
cassiaside|nor-rubrofusarin-6-O-beta-D-glucopyranoside
N-Phenyl-N-(4-D-glucosidurono-phenyl)-thioharnstoff|N-Phenyl-N-<4-D-glucosidurono-phenyl>-thioharnstoff|N-Phenyl-N-<4-hydroxy-phenyl>-thioharnstoff-glucuronid|O1-[4-(N-phenyl-thioureido)-phenyl]-beta-D-glucopyranuronic acid|O1-[4-(N-Phenyl-thioureido)-phenyl]-beta-D-glucopyranuronsaeure
C19H20N2O7S (420.09911700000004)
5-O-(beta-D-glucopyranosyl)-6-O-benzoyl-2,5-dihydroxybenzoic acid|shomaside F
5-Hydroxy-3-methoxy-1-O-beta-D-glucopyranosylxanthone
3-((3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)oxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one
Cassiaside2,3,4-Trihydroxy-3,5-dimethoxypropiophenoneGinsenoside Rg4Methyl dihydrojasmonate1-Dehydroxy-23-deoxojessic acidMalvidin-3-galactoside chlorideTropine4,5-Dioxodehydroasimilobine(2R,3R)-3,7-Dihydroxy-2-(4-hydroxyphenyl)-5-methoxy-8-(3-methylbut-2-en-1-yl)chroman-4-one
Cassiaside is a naphthopyrone glucoside, shows mixed-type inhibition against BACE1 (IC50=4.45 μM; Ki=9.85 μM). Cassiaside possesses potential anti- Alzheimer's disease (AD) activity[1]. Cassiaside is a naphthopyrone glucoside, shows mixed-type inhibition against BACE1 (IC50=4.45 μM; Ki=9.85 μM). Cassiaside possesses potential anti- Alzheimer's disease (AD) activity[1].
Ile-Phe4Cl-OH
C20H21ClN2O6 (420.10880760000003)
Leu-Phe4Cl-OH
C20H21ClN2O6 (420.10880760000003)
Met-Tyr-OH
C19H20N2O7S (420.09911700000004)
Phe4Cl-Leu-OH
C20H21ClN2O6 (420.10880760000003)
Phe4Cl-Ile-OH
C20H21ClN2O6 (420.10880760000003)
2,2,4,6,6,8-hexamethyl-4,8-diphenyl-1,3,5,7,2,4,6,8-tetraoxatetra silocane
C18H28O4Si4 (420.10646080000004)
2,2-[[4-[[6-(methylsulphonyl)benzothiazol-2-yl]azo]phenyl]imino]bisethanol
L-METHIONINE 4-METHYL-7-COUMARINYLAMIDE TRIFLUOROACETATE
2-ethyl-6-hydroxy-5-[(2-methoxy-4-nitrophenyl)azo]-1H-benz[de]isoquinoline-1,3(2H)-dione
Staphcillin
C17H21N2NaO7S (420.09671160000005)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
5-[(3,3-Dimethyl-2-oxido-1-triazen-1-yl)oxy]-2,4-dinitrophenyl 4-(methylamino)benzoate
C16H16N6O8 (420.10295759999997)
2-amino-N-[3-methoxy-5-[oxo-[3-(trifluoromethyl)anilino]methyl]phenyl]-5-oxazolecarboxamide
2-[[Cyclohexyl(oxo)methyl]amino]acetic acid [2-[2-chloro-5-(trifluoromethyl)anilino]-2-oxoethyl] ester
C18H20ClF3N2O4 (420.10636260000007)
2-[3-[(2-Chlorophenyl)methyl]-2-imino-1-benzimidazolyl]-1-(4-nitrophenyl)ethanone
3-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-5,7-dihydroxy-2-(3-hydroxyphenyl)-2,3-dihydrochromen-4-one
2-[3-[(2R)-5-[(6-bromo-1H-indol-3-yl)methyl]-3,6-dioxopiperazin-2-yl]propyl]guanidine
SirReal2
SirReal2 is a potent, isotype-selective Sirt2 inhibitor with an IC50 value of 140?nM and has very little effect on the activities of Sirt3-5. SirReal2 leads to tubulin hyperacetylation in HeLa cells and induces destabilization of the checkpoint protein BubR1[1].
1,3-dihydroxy-7-methoxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]xanthen-9-one
(2s,3r,4r,5s)-5-[2-(3,5-dihydroxybenzoyl)-3-hydroxyphenoxy]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl acetate
1,6-di-o-p-hydroxybenzoyl-β-d-glucopyra-noside
{"Ingredient_id": "HBIN001887","Ingredient_name": "1,6-di-o-p-hydroxybenzoyl-\u03b2-d-glucopyra-noside","Alias": "NA","Ingredient_formula": "C20H20O10","Ingredient_Smile": "C1=CC(=CC=C1C(=O)OCC2C(C(C(C(O2)OC(=O)C3=CC=C(C=C3)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5766","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5,7,4'-trihydroxy dihydroflavonol-3-o-α-l-arabinofuranoside
{"Ingredient_id": "HBIN011234","Ingredient_name": "5,7,4'-trihydroxy dihydroflavonol-3-o-\u03b1-l-arabinofuranoside","Alias": "NA","Ingredient_formula": "C20H20O10","Ingredient_Smile": "C1=CC(=CC=C1C2C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(O4)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21690","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
acetylannulatophenonoside
{"Ingredient_id": "HBIN014448","Ingredient_name": "acetylannulatophenonoside","Alias": "NA","Ingredient_formula": "C20H20O10","Ingredient_Smile": "CC(=O)OC1C(OC(C1O)OC2=CC=CC(=C2C(=O)C3=CC(=CC(=C3)O)O)O)CO","Ingredient_weight": "420.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "321","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "102463820","DrugBank_id": "NA"}
5-({6-[(benzoyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl}oxy)-2-hydroxybenzoic acid
n-{3-[(2r,5r)-5-[(6-bromo-1h-indol-3-yl)methyl]-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]propyl}guanidine
(2s,3s,5s)-3,4,5-trihydroxy-6-[(4-hydroxybenzoyloxy)methyl]oxan-2-yl 4-hydroxybenzoate
3-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-3-yl]oxy}-4-methoxy-4-oxobutanoic acid
2-chloro-1,6,8-trihydroxy-7-(1-hydroxyhexyl)-3-methoxyanthracene-9,10-dione
C21H21ClO7 (420.09757460000003)
5,7-dihydroxy-2-(2-hydroxy-4,5-dimethoxyphenyl)-3,6,8-trimethoxychromen-4-one
1-hydroxy-7-methoxy-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}xanthen-9-one
2-hydroxy-3-methoxy-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}xanthen-9-one
2-chloro-1,3,6,8-tetrahydroxy-7-(1-methoxyhexyl)anthracene-9,10-dione
C21H21ClO7 (420.09757460000003)
5-hydroxy-3-methoxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}xanthen-9-one
2-chloro-1,6,8-trihydroxy-7-[(1s)-1-hydroxyhexyl]-3-methoxyanthracene-9,10-dione
C21H21ClO7 (420.09757460000003)
n-(3-{5-[(6-bromo-1h-indol-3-yl)methyl]-3,6-dihydroxy-2,5-dihydropyrazin-2-yl}propyl)guanidine
(2s,3r)-5,7-dihydroxy-2-(4-hydroxyphenyl)-3-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-2,3-dihydro-1-benzopyran-4-one
(1'r,2s,3r,4s,6r,10's,13's)-3,4,7'-trihydroxy-6-methyl-2',9'-dioxo-12',15'-dioxaspiro[oxane-2,11'-tetracyclo[8.4.1.0¹,¹⁰.0³,⁸]pentadecane]-3',5',7'-trien-13'-ylacetic acid
5-hydroxy-3-methoxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}xanthen-9-one
2-(3,5-dihydroxy-4-methoxyphenyl)-5-hydroxy-3,6,7,8-tetramethoxychromen-4-one
2-hydroxy-3-methoxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}xanthen-9-one
5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]-2,3-dihydro-1-benzopyran-4-one
(3s)-3-{[(2r,3r)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2h-1-benzopyran-3-yl]oxy}-4-methoxy-4-oxobutanoic acid
5,7-dihydroxy-2-(5-hydroxy-2,4-dimethoxyphenyl)-3,6,8-trimethoxychromen-4-one
1,3-dihydroxy-7-methoxy-4-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]xanthen-9-one
5-{[(2s,3r,4s,5s,6r)-6-[(benzoyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-2-hydroxybenzoic acid
1-hydroxy-7-methoxy-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}xanthen-9-one
5,7-dihydroxy-2-(4-hydroxy-2,5-dimethoxyphenyl)-3,6,8-trimethoxychromen-4-one
3,4,7'-trihydroxy-6-methyl-2',9'-dioxo-12',15'-dioxaspiro[oxane-2,11'-tetracyclo[8.4.1.0¹,¹⁰.0³,⁸]pentadecane]-3',5',7'-trien-13'-ylacetic acid
2-(4,5-dihydroxy-2-methoxyphenyl)-5-hydroxy-3,6,7,8-tetramethoxychromen-4-one
2-chloro-1,3,6,8-tetrahydroxy-7-[(1s)-1-methoxyhexyl]anthracene-9,10-dione
C21H21ClO7 (420.09757460000003)